John Mark Sloan

18PUBLICATIONS
50CO-AUTHORS
HaematologyPredictive and prognostic markersHaematological tumoursImmunology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 25, 2025
Incidence of Typical Neutrophil Count With Fy(a-b-) Status Among Hematology Referrals for Neutropenia at an Urban Safety-Net Hospital.

Anya Parekh, Adam Lerner, Reggie R Thomasson

|Mar 19, 2024
The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients.

Rena Zheng, Alexandra Solomon, Madeline DiLorenzo

|Aug 09, 2022
Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational Study.

Ganimete Lamaj, Alberto Pablo-Trinidad, Ian Butterworth

|Jun 22, 2022
Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study.

Joshua N Gustine, Andrew Staron, Raphael E Szalat

|Jul 05, 2021
Primary pulmonary marginal zone lymphoma: an unusual cause of pulmonary infiltrates.

Robert Smyth, John Mark Sloan, Eric Burks

|Jun 20, 2020
Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen.

Brett Dumas, Hassan Yameen, Shayna Sarosiek

Pageof 3

Frequent Collaborators

14 joint publications

Vaishali Sanchorawala

6 joint publications

Shayna Sarosiek

3 joint publications

Andrew Staron

2 joint publications

Karen Quillen